SEC Comment Letter for CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) (CAPR) — Oct 7, 2013
CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)
Date: Oct. 7, 2013 · CIK: 0001133869 · Accession: 0000000000-13-055108
AI Filing Summary & Sentiment
Reasoning
Letter
October 7, 2013 Via E -mail Daron Evans Chief Financial Officer Nile Therapeutics, Inc. 63 Bovet Rd., Suite 421 San Mateo, California 94402
Re: Nile Therapeutics, Inc. Preliminary Proxy Statement on Schedule 14A Filed October 4, 2013 File No. 001 -34058
Dear Mr. Evans :
We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all per sons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/ Daniel Greenspan for
Show Raw Text
October 7, 2013 Via E -mail Daron Evans Chief Financial Officer Nile Therapeutics, Inc. 63 Bovet Rd., Suite 421 San Mateo, California 94402 Re: Nile Therapeutics, Inc. Preliminary Proxy Statement on Schedule 14A Filed October 4, 2013 File No. 001 -34058 Dear Mr. Evans : We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all per sons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Daniel Greenspan for Jeffrey P. Riedler Assista nt Director cc: Via E -Mail Christopher J. Melsha Fredrikson & Byron, P.A. 200 South Sixth Street, Suite 4000 Minneapolis, MN 55402